Hercules Capital Inc $ 16.05 0.42 (2.69%)
Warning! GuruFocus has detected 3 Severe warning signs with HTGC. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for HTGC (Hercules Capital Inc) from 2005 to Feb 25 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Hercules Capital stock (HTGC) PE ratio as of Feb 25 2021 is 14.85. More Details
Hercules Capital PE Ratio (TTM) Historical Data
View and export this data going back to 2005. Start your Free Trial
Hercules Capital PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare NYSE:WD OTCPK:FMCC NAS:ECPG NAS:COOP NYSE:EFC NYSE:CNF NAS:ATAX NAS:ASPS NAS:MRCC NAS:MMAC NSE:HDFC HKSE:03360 NAS:TREE NYSE:ESNT NYSE:PFSI OTCPK:FNMA HKSE:00056 NSE:LICHSGFIN LSE:OSB TSX:FN
Address 400 Hamilton Avenue, Suite 310, Palo Alto, CA, USA, 94301
Hercules Capital Inc is a specialty finance company engaged in providing senior secured loans to high-growth, venture capital-backed companies in a variety of technology, life sciences, and sustainable and renewable technology industries. It invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The company lends to and invests in portfolio companies in various technology-related industries including technology, drug discovery and development, biotechnology, life sciences, healthcare, and sustainable and renewable technology.